about
Syncope risk stratification tools vs clinical judgment: an individual patient data meta-analysis.Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceryl trinitrate in older patients with recurrent unexplained syncope.Mechanism of syncope in patients with positive adenosine triphosphate tests.Clinical spectrum of neurally mediated reflex syncopes.Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study.[Syncope and bundle branch block: an unsolved problem].[How is syncope studied in the Italian hospitals?].Relation of clinical presentation of syncope to the age of patients.Diagnosis and characteristics of syncope in older patients referred to geriatric departments.[Evaluation of "complex syncope: what are the indications for second-level investigations?].Prospective multicentre systematic guideline-based management of patients referred to the Syncope Units of general hospitals.Early and late outcome of treated patients referred for syncope to emergency department: the EGSYS 2 follow-up study.[The Syncope Unit: a new organizational model for the management of patients with syncope].Discrepancy between clinical practice and standardized indications for an implantable loop recorder in patients with unexplained syncopeDiagnosis, management, and outcomes of patients with syncope and bundle branch block.Nitrate-potentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope.Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes.Syncope clinical management in the emergency department: a consensus from the first international workshop on syncope risk stratification in the emergency departmentStandardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncope: 3-year insights from the Syncope Unit Project 2 (SUP 2) study.Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial.
P50
Q30826820-02D06A07-D96F-4E6D-962D-0CD2B93CEBE4Q33147973-0246AF00-FC6C-45BE-A1E2-E746388977ADQ33148558-2C793999-46ED-4680-967D-F8962221F06AQ33150843-D3860916-17D2-4178-BCBB-0A9219E35496Q33151331-C502F3D5-5F86-4C06-A56B-4714FB03362CQ33151587-BA9B4548-8EE4-4835-A806-67A1F6E5F9B6Q33151893-43BCFF11-00A7-489A-8245-51FE9AA62836Q33153274-2B0D23FF-10D6-4889-B4D5-62D39CF18F0AQ33154359-1B5AADC0-0CC3-416D-96D1-09515B8435D3Q33157220-E5456B22-0A9D-45A0-B136-C0D3FFA813CFQ33158104-F38AB5B9-3A85-4BE4-86AE-4FDED6542F53Q33158397-0D500607-BEAE-4FC8-9B05-E06B314F1C67Q33159043-68FAF55F-DFCF-46E3-9743-4F298A713A8FQ33159251-AE76086C-C361-4CED-B506-64CA8C9663FAQ33159871-78045CE4-BF6A-4188-ACBA-122F0E39306DQ33163209-BDBA866A-1EF9-48A2-8DF0-B932A1549A11Q33165520-19D880E9-6FA6-4EAD-900F-17E24F3CAB31Q33166081-AEE53E97-5FA5-4F83-A830-49CD31E7CD61Q33166495-368C3CA8-FCFE-41B6-938E-FCC383ED80F9Q33168582-88918F49-5CAA-40E0-8D2E-D707BA9503A2
P50
description
onderzoeker
@nl
name
Attilio Del Rosso
@ast
Attilio Del Rosso
@en
Attilio Del Rosso
@es
Attilio Del Rosso
@nl
Attilio Del Rosso
@sl
type
label
Attilio Del Rosso
@ast
Attilio Del Rosso
@en
Attilio Del Rosso
@es
Attilio Del Rosso
@nl
Attilio Del Rosso
@sl
prefLabel
Attilio Del Rosso
@ast
Attilio Del Rosso
@en
Attilio Del Rosso
@es
Attilio Del Rosso
@nl
Attilio Del Rosso
@sl